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The goal of FOCUS, which stands for Frailty Management Optimization through EIPAHA Commitments and Utiliza-
tion of Stakeholders’ Input, is to reduce the burden of frailty in Europe. The partners are working on advancing knowledge of 
frailty detection, assessment, and management, including biological, clinical, cognitive and psychosocial markers, in order to 
change the paradigm of frailty care from acute intervention to prevention. FOCUS partners are working on ways to integrate 
the best available evidence from frailty-related screening tools, epidemiological and interventional studies into the care of frail 
people and their quality of life. Frail citizens in Italy, Poland and the UK and their caregivers are being called to express their 
views and their experiences with treatments and interventions aimed at improving quality of life. The FOCUS Consortium is 
developing pathways to leverage the knowledge available and to put it in the service of frail citizens. In order to reach out to 
the broadest audience possible, the FOCUS Platform for Knowledge Exchange and the platform for Scaling Up are being de-
veloped with the collaboration of stakeholders. The FOCUS project is a development of the work being done by the European 
Innovation Partnership on Active and Healthy Ageing (EIPAHA), which aims to increase the average healthy lifespan in Europe 
by 2020 while fostering sustainability of health/social care systems and innovation in Europe. The knowledge and tools devel-
oped by the FOCUS project, with input from stakeholders, will be deployed to all EIPAHA participants dealing with frail older 
citizens to support activities and optimize performance.
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Background
The FOCUS (Frailty Management Optimisation through 
EIPAHA Commitments and Utilisation of Stakeholders’ In-
put) project aims to critically reduce and prevent the bur-
den of frailty in Europe by supporting development of the 
commitments that focus on early diagnosis/screening and 
on management of frailty within the European Innovation 
Partnership for Active Healthy Ageing (EIPAHA). Prevention, 
early diagnosis and management of frailty pose a series of 
challenges, which add to the many gaps still existing in the 
fluid exchange with stakeholders.
The EIPAHA was selected because it constitutes a criti-
cal instrument for the EU and because it composes the wid-
est representation of initiatives regarding frailty in Europe. 
Facilitation of exchange of best practice and the support of 
networks for knowledge sharing have been taken as objec-
tives in the project.
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Frailty and ageing
Ageing is understood as a biological process resulting 
from the gradual, lifelong accumulation of molecular and 
cellular damage [1]. This burden produces a clinical pheno-
type where both frailty and disease are common outcomes.
Frailty is defined as a state of high vulnerability for ad-
verse health outcomes when exposed to a stressor [2]. As 
a consequence, frailty associates with disease, dependency 
and death that, among other adverse and obvious outcomes, 
entail a high demand and utilization of health and commu-
nity services and other resources [3–8]. although there is 
no unique conceptualization of frailty [9–11], the two most 
widely accepted models identify an overlapping population 
at high risk of poor prognosis [12–13]. Depending on the defi-
nition selected, estimates of frailty vary from 4% to 17% [14].
The impact of ageing is malleable, as is frailty, which 
is seen as a continuum with a pre-frail state identified [2]. 
Evidence suggests that lifestyle and other interventions may 
help to slow down the ageing impacts. There is therefore 
scientific consensus that, given both high prevalence and 
impact on health, screening and prevention for frailty at 
population level is recommended [15].
Some risk factors have been associated with frailty. Poly-
pharmacy, for example, has been recognized as an indepen-
dent risk factor for development of a vulnerable state [16–
18]. Indeed, focus on frailty has been the driver for initiatives 
aiming at the modification of healthcare systems. A change 
from an organization focused around single-system illnesses 
(disease oriented approach) towards a more holistic view-
point of the patient (patient oriented approach), involving 
coordinated health and social interventions, would result.
However, there are many uncertainties around the strat-
egies to identify and tackle frailty. Together with the different 
approaches in screening and diagnosis, there is insufficient 
information on the regulatory pathophysiological pathways, 
and there is a lack of models to assess the value of the im-
pact on health economy.
Finally, there is a deficiency in personalised integrated 
solutions. Together, these uncertainties at present translate 
into a lack of effective management guidelines.
The need for a comprehensive consideration of the main 
clinical conditions affecting ageing is reflected by the 2014 
Annual Work Programme for the implementation of the 
third programme of the union’s action in the field of health 
(2014–2020), where frailty, multi-chronic conditions (multi-
morbidity), and integrated care are placed within the same 
action under thematic priority [19].
There is a growing interest in frailty. The search engine 
PubMed for this key-word shows an exponential increase of 
titles, accumulating in the last 10 years. The body of knowl-
edge regarding this conception is represented in the form of 
systematic reviews or other similar forms of scientific litera-
ture, which provide the evidence-based practice available 
at the present time.
As detailed later, a principal objective of the FOCUS 
project is to consolidate the up-to-date evidence-based in-
formation about frailty, together with the related measures 
and methods. 
Frailty in the European Union
The Innovation Union strategy [19] was launched by 
the European Commission to face major societal challenges 
claiming for innovation emergency. After specific scrutiny, 
some dysfunctions have been detected by an ad hoc created 
Independent Expert Group, which has recommended a list 
of interventions [20]. particularly: an ecosystem approach 
facilitating the implementation of innovation and the collab-
oration between actors as well as the integration of new ac-
tors, more effective sharing of knowledge and the identifica-
tion of appropriate indicators capable of effectively tracking 
the overall development, or improvement of the stakeholder 
engagement to ease synergies or policy maker commitment.
European Innovations Partnership (EIP) was created to 
establish a forum for exchange and to improve cooperation 
between actors, but dysfunctions have been detected. Com-
missioned by the Union, the Expert Group [2] recommend-
ed a new ecosystem for innovation and scaling-up, where 
optimisation will include improvements in knowledge ex-
change, and where a collaborating platform will facilitate 
synergies. Also, strengthening the bottom-up approach, with 
a definitive reinforcement in the participation of partners 
and stakeholders, should combine with the necessary top-
down leadership. Finally, the need for continual monitoring 
and evaluation will require the development of appropriate 
indicators and methodology.
EIPAHA was launched in May 2011. Since then, almost 
600 commitments have been submitted by an array of stake-
holders. Frailty has been specifically tackled in the action 
groups. For example, one of the action groups, A3, specifical-
ly focuses in the prevention of functional decline and frailty.
Together with monitoring, much of the activity in the 
Action Groups has concentrated in promoting exchange for 
speeding up progression. The initiatives to advance in that 
regard have substantiated into: the introduction of common 
tasks, the use of a social network for facilitating contact, 
groups meetings with responsible Commission officers, an-
nual conferences and specific inter-groups activities.
The key factors described by the experts and promoted 
within EIPAHA, all mentioned above, define the basis for 
optimisation, in which this project is based.
Objectives of the Project
The main goal of FOCUS project is to contribute to the 
reduction of the burden created by frailty by introducing 
innovative practices leading to optimization of the perfor-
mance of EIPAHA.
The following specific objectives have been defined:
1. To consolidate the available evidence regarding 
screening and interventions for frailty and pre-frailty 
from the published literature.
2. To gain knowledge and understanding of the needs 
of stakeholders (including citizens, patients, carers, 
providers, policy makers, etc.), regarding frailty: 
care, social support, prevention.
3. To examine critically the reality of the commitments 
in EIPAHA that deal with frailty screening, preven-
tion or management.
4. To identify possible targets for customized strate-
gies aimed at optimization and scalability within 
EIPAHA through an analytical and standardized 
characterization and comparison of EIP AHA in-
terventions. This will focus on common indicators 
and the projections of their impact on resource con-
sumption at population-level.
5. To develop guidelines as a customized service to 
aid implementation, optimization and scalability 
supported by the functionality of an ICT platform.
6. To create a network representative of European di-
versity, including a balanced representation of part-
ners in commitments and stakeholders representa-
tive of European diversity.
7. To deploy the PKE (Platform for Knowledge Ex-
change), a technological platform to support the 
remote access and scaling up of the good practice 
modules resulting from this project.
8. To assess performance of the generated guidelines 
through a test performed on the set of EIPAHA com-
mitments that are being run by partners in the con-
sortium.
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Methodology
Several approaches are combined in the framework of 
a participatory research design. Quantitative approaches will 
be used in two systematic reviews, one related to reliabil-
ity, validity and ability to predict adverse health outcomes of 
existing frailty tools, another about the effectiveness of inter-
ventions in preventing the progression pre-frailty and frailty. 
Moreover quantitative approaches will be used in the analy-
ses of the characteristics of the activities represented in the 
EIP-AHA, comparative effectiveness analyses, and in the use 
of models predictive of resource consumptions according 
to needs. A qualitative approach will be used for the meta-
synthesis of several stakeholders’ opinions and experiences 
about screening and management of frailty and in the five 
focus groups with different stakeholders conducted in three 
countries. Also, a mixed-method approach will be used to 
develop indicators of quality of the EIP-AHA activities will 
be developed with a mixed-method approach since they will 
be derived from several sources, including the focus groups 
findings, and a Delphi for the final selection. 
Finally, stakeholders will be involved in the definition of 
the characteristics of the platform for knowledge exchange 
through surveys collecting their needs and preferences, and 
suggestions. to specify, the tools employed are:
• Quality appraisal resulting in final sets of papers for 
analyses and draft of conclusions and recommenda-
tions (objective 1, objective 2);
• Focus groups meetings including stakeholders: frail 
and non-frail older adults, caregivers, health and so-
cial care professionals, (objective 2);
• Structured surveys (objective 3);
• Delphi consensus (objective 4);
• Skype conferences (objective 4, objective 5, objec-
tive 6, objective 7, objective 8);
• Email contacts (objective 4, objective 7);
• On site meetings (objective 6, objective 7, objec-
tive 8);
• Virtual meetings of the network (objective 8).
Target groups 
The FOCUS Consortium has identified four levels of tar-
gets groups of its activities. The first, immediate target group 
is constituted of the growing population of ageing people 
within the EU, together with their caregivers. The second, 
the stakeholders, who will be given a channel to directly ex-
press their needs at a European scale. In addition to patients 
and their caregivers, already considered preferentially as the 
first target, health care professionals, knowledge institutes, 
SMEs, service providers, insurance companies, policy mak-
ers, are further examples of this group. The third are the part-
ners dealing with frailty screening and management within 
the specific sector in EIPAHA. A substantial improvement 
in the respective performance of the affected commitments 
will ensue.
The fourth target group is constituted by the Member 
States. Advances having an impact on citizens affected by 
frailty will result in real consolidation of profiles where em-
powerment of citizens, sustainability and trans-European 
standardization will become a more prevalent reality. The 
corresponding impact on cross-border issues will ensure this 
becomes a more permanent reality across Europe.
Political relevance 
In consistence with the EU Regulation No 282/2014 of 
the European Parliament and of the Council of March 2014, 
and of the Commission White paper “together for Health: 
a strategic approach for the eu 2008–2013”, the Work 
Program stresses four specific objectives, the first being the 
promotion of health, and the third being the contribution to 
innovative, efficient and sustainable health systems.
The FOCUS project contributes to health promotion, as 
clearly stated throughout the previous pages; it is innovative, 
because it addresses gaps in early diagnosis and associated 
frailty management in Europe; it promotes the optimisation 
of the work being conducted by existing commitments, by 
deploying appropriate instruments and fostering a prioritised 
participation of stakeholders, leading to the spread of cus-
tomised guidelines to improve performance developed by 
the FOCUS project with stakeholders input; it is compatible 
with existing actions: for example, scalability will be based 
on the knowledge being generated by a FP7 funded proj-
ect, Perssilaa (www.perssilaa.eu); it participates in networks 
funded under the EU Health Programs, since seven of the 
partners in the consortium are members of EIPAHA.
According to Eurostat Population Projections, the num-
ber of people aged 65+ in the EU will grow by 70% by 
2050 [19]. Frailty dramatically ruins what otherwise would 
be healthy ageing, and this is a first level public health is-
sue. Consequently, the added value in public health of the 
FoCus project derives from: the impact on the target group, 
frail and pre-frail citizens in this case and the multiplier ef-
fect, expected through the improvement in the performance 
of EIPAHA commitments. EIPAHA constitutes a huge net-
work whose impact is extraordinary. Accordingly, the proj-
ect will act as a chain reaction, due to the amplifying power 
constituted by EIPAHA. 
The closeness to the needs expressed by stakeholders 
will be expressed in the generation of the database for anal-
ysis and will be permanently represented in the network. 
Among them, policy makers represent an enormous impact 
potential (macro-level). Vice versa, the inclusion of final us-
ers (caregivers, non-government organisations, patients as-
sociations, etc.) warrants the bottom-up approach. The fa-
vorable reception of these organisations in public opinion 
plus the enormous impact of volunteerism offer a powerful 
catalytic effect.
Finally, the FOCUS project helps partners in EIPAHA, 
and in that sense, promotes best practice, creates bench-
marking for decision making, strengthens networking, man-
ages in a particularly excellent way the cross border issues, 
and because it finally helps the EIPAHA to implement EU 
legislation.
Pertinence of geographical coverage
The actual consortium constitutes an equilibrated and 
large representation of the geography in the European Union. 
Centre-North (the Netherlands) and South (Spain and Italy), 
East (Poland) and West (UK, Portugal) have a representation. 
This large representation makes it possible to include different 
profiles of citizens with regards to pre-frailty and frailty, which 
has implications in screening and management. Frailty/pre-
frailty is a pressing need all over Europe, but has different 
faces in the South as compared with the North, for example.
The European Union is a contrasting reality, with dif-
ferences affecting life expectancy (LE) and healthy-life years 
(HLy). the FoCus project is sensitive to the cultural diver-
sity and the cross border issues because it works with part-
ners and commitments from all over Europe. The views, social 
contexts, customs, local policies, and other related matters 
are adequately represented. Moreover, the use of real time 
Information and Communication Technologies (ICTs) may 
speed up the optimisation in practices and the correspond-
ing benefit for citizens, even in Member States undergoing 
economic crises and reduction in available resources.
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within EIPAHA, and the needs expressed by stake-
holders.
• It will evaluate the appropriateness of strategies iden-
tified through newly generated guidelines. Relevant, 
responsive, and scientifically sound indicators will 
help in the process.
• It will create a technological platform for perpetu-
ating the fruitful exchange between EIPAHA part-
ners and stakeholders, the Platform for Knowledge 
Exchange. Other functionalities repository, etc.) will 
amplify the utility of the platform.
Finally, it will test guidelines for impact in the real world 
represented by commitments run by partners in the consor-
tium. Feedback from the experience will help to further op-
timise guidelines.
Expected outcomes
The deliverables of the FOCUS project will offer sig-
nificant potential improvements for innovative, coordinated 
and comprehensive community based prevention with regard 
to the optimization of functional capacity tools to address 
pre-frailty, and for improving the management of frailty. In 
doing that the project focuses on EIPAHA as the European 
level forum where is a solid representation of partners and 
stakeholders.
specifically:
• It will provide a detailed appraisal of those most rel-
evant variables to take into account in the process of 
building the most suitable strategy, i.e. the state of the 
art, the reality of commitments working in the field 
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